Subscribe to news

HSCI Announces Results of Annual General Shareholders’ Meeting

Moscow – 21 June 2017.   The Human Stem Cells Institute (“HSCI”, MOEX: ISKJ), one of Russia’s leading biotech companies, today announced the results of its Annual General Shareholders’ Meeting (AGM) held on June 21, 2017 in Moscow.

Voting at the AGM, shareholders adopted, among others, the following decisions:


  • Shareholders approved HSCI’s Annual Report and Annual Financial Statements prepared according to Russian Accounting Standards, including the Company’s profit and loss statement, for the 2016 fiscal year. 
  • Shareholders elected a new Board of Directors, which includes the following directors, 3 of which are independent:

1. Dmitry Alexandrov, Deputy General Director for Investments, UNIVER Capital; independent director;
2. Roman Deev, Head of Pathoanatomy Department at Ryazan State Medical University; Chief Scientific Officer of HSCI;
3. Artur Isaev, General Director of HSCI;
4. Andrey Isaev, General Director of Segment LLC;
5. Sergey Kiselev, Head of the Lab at the Federal scientific-clinical center of physical-chemical medicine, independent director;
6. Boris Maizel, independent director;
7. Alexander Prikhodko, Deputy General Director of HSCI.

According to HSCI’s Charter, the Company’s Board of Directors consists of 7 members.

  • Members of the Audit Commission were elected:

1. Svetlana Blokhina, Financial Control and Internal Audit Officer of HSCI;
2. Oksana Peterson, Deputy Chief accountant of HSCI;
3. Svetlana Samoylova, Director for Investor Relations of HSCI.

According to HSCI’s Charter, the Company’s Audit Commission consists of 3 members.

  • Shareholders approved ReKa-Audit LLC (Moscow region) as HSCI’s external auditor for the 2017 fiscal year.
  • The restated versions of the Company’s Internal Regulations (The Charter, Regulations on the General Shareholders’ Meeting, Regulations on the Board of Directors) were adopted. They have been updated to meet the amended requirements of the Russian legislation on joint stock companies concerning major and related- party transactions approval and GSM convocation. 
  • Shareholders decided to pay members of the Company’s Board of Directors compensation in a sum of 80,000 (eighty thousand) rubles, including income tax, to each director.

Full Version of the Press Release 


21 June 2017